Skip to content

The Study on Insulin Secretion and Insulin Action in Ketosis-prone Type 2 Diabetes

The Study on Insulin Secretion and Insulin Action in Ketosis-prone Type 2 Diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ECS-07000063
Enrollment
Unknown
Registered
2006-11-06
Start date
2008-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ketosis-prone type 2 diabetes

Interventions

Obese ketosis-prone diabetes (Obese-KPD) group:none
New-onset type 2 diabetes without diabetic ketosis:none
Health Control (HC):none
Lean ketosis prone diabetes (Lean-KPD):none

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. All patients admitted to West China Hospital who meet diagnosis criteria of DKA; 2. Willing to participate in the study protocol; 3. New-onset diabetes within half a year according to the consensus reports of the Experts Committee on Diagnosis and Classification of Diabetes Mellitus and WHO in 1999; 4. Diagnostic Criteria for DKA: Blood glucose >250 mg/dL, arterial or venous pH 3+ or serum beta-hydroxybutyrate >3 mmol).

Exclusion criteria

Exclusion criteria: 1. Those taking medication to alter glucose metabolism; 2. Those with ischemic cardiovascular or cerebrovascular or peripheral vascular diseases; 3. Those having congestive heart failure, anemia, hepatic or renal dysfunction; 4. Pregnancy or bread-feeding; 5. Patients with dementia or persistent altered mental status that would prevent collection of consent form and reliable information; Health Control: The control group was health volunteer. The control subjects had to fulfill the following inclusion criteria: (a) Age from 30 to 55 yrs; (b) No diabetes; (c) First degree relatives without a history of diabetes; (d) No drug treatment nor any disease that could potentially disturb carbohydrate metabolism; (e) BMI within the range of mean± SD of the BMI of the Obese and Lean-groups; (f) No history of hypertension. Altogether, subjects met the inclusion.

Design outcomes

Primary

MeasureTime frame
Glucose disposal rate (GDR);Serum antibodies;AIRg;

Secondary

MeasureTime frame
Clinical characteristics;Laboratory characteristics;

Countries

China

Contacts

Public ContactYerong Yu
yerongyu04@yahoo.com.cn+86 28 85422362

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026